Addex Therapeutics Ltd
ADXN | NASDAQ
$3.53
+$0.13 (+3.98%)
At close: Sep 21, 2026, 4:00 PM ET
$3.31
-$0.22 (-6.23%)
After-hours:
Sep 21, 2026, 7:45 PM ET
Market Data
Market Cap $4.19M
Enterprise Value $2.64M
Beta 1.96
Average Volume 94.79K
Shares Outstanding (Diluted) 1.43M
Shares Change YoY 74.12%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US00654J2069
Price Performance
Price Change 1M -20.9%
Price Change 3M -45.3%
Price Change 6M -45.8%
Price Change YTD -56.4%
Price Change 1Y -63.5%
Price Change 3Y -51.8%
Price Change 5Y -98.2%
1M CAGR (ann.) -41.4%
1Y CAGR (ann.) -68.7%
5Y CAGR (ann.) -55.1%
All-Time CAGR -47.0%
Valuation
PE Ratio -0.42
Forward PE N/A
PEG Ratio 0.00
Forward PEG 0.02
PS Ratio 47.09
Forward PS 0.60
PB Ratio 1.06
P/FCF Ratio -1.50
P/Adj. FCF Ratio -1.48
P/OCF Ratio -1.73
EV/Sales 35.65
EV/EBIT -0.37
EV/EBITDA -0.37
EV/FCF -1.13
Earnings Yield -234.7%
FCF Yield -65.2%
Adj. FCF Yield -65.8%
Financial Health
Net Cash CHF937.5K
Total Debt CHF102.27K
Cash & Short-Term Investments CHF937.5K
Total Assets CHF4.76M
Current Ratio 0.97
Quick Ratio 0.97
Debt / Equity Ratio 0.03
Debt / EBITDA -0.01
Debt / FCF -0.04
OCF / Debt -22.76
Interest Coverage -145.69
Altman Z-Score -109.97
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 84.3%
Operating Profit Margin -3630.8%
EBITDA Margin -5331.1%
Net Profit Margin -7775.2%
FCF Margin -3143.4%
Adj. FCF Margin -3174.3%
SBC / Revenue 25.6%
SBC Impact (per share) -1.0%
Returns
Return on Assets -146.4%
Return on Equity -131.3%
Return on Invested Capital -74.4%
Return on Capital Employed -76.0%
Return on Tangible Assets -146.4%
Historical Growth (CAGR)
Revenue CAGR 3Y -64.7%
Revenue CAGR 5Y -53.9%
Revenue CAGR 10Y -22.0%
EPS CAGR 3Y 110.4%
EPS CAGR 5Y 70.0%
EPS CAGR 10Y 10.1%
FCF CAGR 3Y 59.2%
FCF CAGR 5Y 43.8%
FCF CAGR 10Y -5.6%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 1
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 8, 2026
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $30
Price Target Upside 749.9%
Cash Flow
Operating Cash Flow CHF-2.33M
Free Cash Flow CHF-2.33M
Adj. Free Cash Flow CHF-2.35M
FCF Per Share -$1.64
OCF Per Share -$1.64
OCF/S Ratio -2609.7%
Income Statement
Revenue CHF74.04K
Gross Profit CHF-196.55K
Operating Income CHF-2.69M
EBITDA CHF-7.06M
Net Income CHF-6.97M
EPS (Diluted) -$6.80
Revenue / Employee $24.68K
Profit / Employee $-2.32M
Employees 3
Add to Watchlist
Select watchlists to add or remove ADXN